Arrogene

Developer of cancer therapeutics based on a nanotechnological targeting platform

placeLos Angeles, California, United States calendar_todayFounded 2007 language arrogene.com

Registered entities

Innovation

3 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 12 times.

YearFilings
20191

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon